Matches in SemOpenAlex for { <https://semopenalex.org/work/W4307804936> ?p ?o ?g. }
Showing items 1 to 76 of
76
with 100 items per page.
- W4307804936 endingPage "A115" @default.
- W4307804936 startingPage "A114" @default.
- W4307804936 abstract "Abstract Background Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency (21-OHD) is an autosomal recessive disorder characterized by insufficient cortisol production resulting in excess adrenal androgen production. The standard of care to replace the insufficient cortisol production is the lifelong use of glucocorticoids (GCs), usually at supraphysiologic levels to control hyperandrogenemia. Chronic use of supraphysiologic GCs is associated with long-term comorbidities. The degree of patient awareness of GC associated comorbidities is unknown and of critical importance to focus patient education. Methods An online survey was conducted in the US and promoted through a nationally known patient advocacy organization and through social media. Survey questions assessed the perceptions of patients living with CAH regarding their GC regimens, most common side effects associated with GCs, patients understanding of the risk and benefit of GC use and patients’ attitude about adjusting their GC regimen. Results A total of 113 patients living with CAH completed the online survey. Over 97.5% reported taking GCs at the time of the survey, with 75% being satisfied and 85% rating their regimen effective or very effective. Commonly reported side-effects associated with GC use included increased weight gain and appetite, fatigue, moon face, thin skin that bruises easily, and mood changes or depression. Less common side effects included osteoporosis, muscle weakness, high blood pressure and increased infections. Approximately half reported discussing the long-term risks of GC treatment with their healthcare provider, with the remaining half reported not having this discussion or were unsure. Approximately 43% of respondents reported being in situations where they were not given enough information about the risk of supraphysiologic GC use to make an informed decision on treatment. A majority of respondents (67%) reported a willingness to change their current regimen if there was a safe and effective way to reduce their current GC dose closer to physiologic levels. Conclusions While a majority of patients living with CAH are satisfied with their current GC regimen, there is a general lack of patient awareness of the long-term side effects associated with supraphysiologic GCs. Patients may benefit from more patient education to make informed decisions with their healthcare providers. Presentation: Saturday, June 11, 2022 1:00 p.m. - 3:00 p.m." @default.
- W4307804936 created "2022-11-06" @default.
- W4307804936 creator A5030318670 @default.
- W4307804936 creator A5031424617 @default.
- W4307804936 creator A5038340896 @default.
- W4307804936 creator A5087176342 @default.
- W4307804936 date "2022-11-01" @default.
- W4307804936 modified "2023-10-14" @default.
- W4307804936 title "PSAT082 A Survey of Patients Living with CAH Assessing Their Perceptions on Glucocorticoid Regimen and Glucocorticoid-Associated Side Effects" @default.
- W4307804936 doi "https://doi.org/10.1210/jendso/bvac150.233" @default.
- W4307804936 hasPublicationYear "2022" @default.
- W4307804936 type Work @default.
- W4307804936 citedByCount "0" @default.
- W4307804936 crossrefType "journal-article" @default.
- W4307804936 hasAuthorship W4307804936A5030318670 @default.
- W4307804936 hasAuthorship W4307804936A5031424617 @default.
- W4307804936 hasAuthorship W4307804936A5038340896 @default.
- W4307804936 hasAuthorship W4307804936A5087176342 @default.
- W4307804936 hasBestOaLocation W43078049361 @default.
- W4307804936 hasConcept C118552586 @default.
- W4307804936 hasConcept C126322002 @default.
- W4307804936 hasConcept C139719470 @default.
- W4307804936 hasConcept C162324750 @default.
- W4307804936 hasConcept C1862650 @default.
- W4307804936 hasConcept C187212893 @default.
- W4307804936 hasConcept C199360897 @default.
- W4307804936 hasConcept C2776541429 @default.
- W4307804936 hasConcept C2776867660 @default.
- W4307804936 hasConcept C2777767042 @default.
- W4307804936 hasConcept C2778722290 @default.
- W4307804936 hasConcept C2780733359 @default.
- W4307804936 hasConcept C2780841215 @default.
- W4307804936 hasConcept C2781413609 @default.
- W4307804936 hasConcept C3454156 @default.
- W4307804936 hasConcept C41008148 @default.
- W4307804936 hasConcept C558461103 @default.
- W4307804936 hasConcept C71924100 @default.
- W4307804936 hasConceptScore W4307804936C118552586 @default.
- W4307804936 hasConceptScore W4307804936C126322002 @default.
- W4307804936 hasConceptScore W4307804936C139719470 @default.
- W4307804936 hasConceptScore W4307804936C162324750 @default.
- W4307804936 hasConceptScore W4307804936C1862650 @default.
- W4307804936 hasConceptScore W4307804936C187212893 @default.
- W4307804936 hasConceptScore W4307804936C199360897 @default.
- W4307804936 hasConceptScore W4307804936C2776541429 @default.
- W4307804936 hasConceptScore W4307804936C2776867660 @default.
- W4307804936 hasConceptScore W4307804936C2777767042 @default.
- W4307804936 hasConceptScore W4307804936C2778722290 @default.
- W4307804936 hasConceptScore W4307804936C2780733359 @default.
- W4307804936 hasConceptScore W4307804936C2780841215 @default.
- W4307804936 hasConceptScore W4307804936C2781413609 @default.
- W4307804936 hasConceptScore W4307804936C3454156 @default.
- W4307804936 hasConceptScore W4307804936C41008148 @default.
- W4307804936 hasConceptScore W4307804936C558461103 @default.
- W4307804936 hasConceptScore W4307804936C71924100 @default.
- W4307804936 hasIssue "Supplement_1" @default.
- W4307804936 hasLocation W43078049361 @default.
- W4307804936 hasLocation W43078049362 @default.
- W4307804936 hasOpenAccess W4307804936 @default.
- W4307804936 hasPrimaryLocation W43078049361 @default.
- W4307804936 hasRelatedWork W2003753480 @default.
- W4307804936 hasRelatedWork W2005983610 @default.
- W4307804936 hasRelatedWork W2139162702 @default.
- W4307804936 hasRelatedWork W2353418508 @default.
- W4307804936 hasRelatedWork W2358908083 @default.
- W4307804936 hasRelatedWork W2369307716 @default.
- W4307804936 hasRelatedWork W2370027571 @default.
- W4307804936 hasRelatedWork W2761611463 @default.
- W4307804936 hasRelatedWork W2939622041 @default.
- W4307804936 hasRelatedWork W4247064585 @default.
- W4307804936 hasVolume "6" @default.
- W4307804936 isParatext "false" @default.
- W4307804936 isRetracted "false" @default.
- W4307804936 workType "article" @default.